Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.
about
Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritisCardiorheumatology: cardiac involvement in systemic rheumatic diseaseOxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipidsRisk of venous thromboembolism in patients with celiac disease: A systematic review and meta-analysis.Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis.Myocardial ischemia in Wegener's granulomatosis: coronary atherosclerosis versus vasculitis.Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcificationStudy of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.Evaluation of Antiarthritic Potential of Methanolic Extract of Gentiana kurroo Royle.The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trialEffects of some acupoints (Du-14, Li-11, St-36, and Sp-6) on serum TNF-α and hsCRP levels in healthy young subjectsCardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis.Oxidative changes in the blood and serum albumin differentiate rats with monoarthritis and polyarthritisXH-14, a novel danshen methoxybenzo[b]furan derivative, exhibits anti-inflammatory properties in lipopolysaccharide-treated RAW 264.7 cellsThe effect of sub-antimicrobial dose-doxycycline periodontal therapy on serum inflammatory biomarker C-reactive protein levels in post-menopausal Women: A 2-year, double-blinded, randomized clinical trialCelastrus treatment modulates antigen-induced gene expression in lymphoid cells of arthritic ratsOxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways.Ankylosing spondylitis and risk of venous thromboembolism: A systematic review and meta-analysisRheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-α and IL-1β in PBMCs.Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin.Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link.Development of the International Classification of Functioning, Disability and Health core sets for hand conditions--results of the World Health Organization International Consensus process.CD154: the atherosclerotic risk factor in rheumatoid arthritis?Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis.Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis.Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis.Coronary artery disease in primary biliary cirrhosis: A systematic review and meta-analysis of observational studies.Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013.Systemic sclerosis and risk of venous thromboembolism: A systematic review and meta-analysis.Risk of ischemic stroke in patients with systemic sclerosis: A systematic review and meta-analysis.Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects.Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis.Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases.Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.Accelerated transformation of macrophage-derived foam cells in the presence of collagen-induced arthritis mice serum is associated with dyslipidemia.Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies.
P2860
Q26750562-9D892622-28B1-435A-A2BE-10F2D63E6387Q27008927-EEEBB032-0F7D-4AC0-A0FD-EF36298C85F8Q28752575-5E440DD4-739B-4BF6-9045-3C669D2FA758Q30251989-5E2C23AA-9D60-41CB-8A3A-D48AA665E6E8Q30252078-0AA49A4F-86AC-4327-9ADC-3C30DFE12C48Q33760303-3107DBF0-A573-4E77-969F-690338D659BEQ33891946-337E71BF-4854-44DB-9B46-BF38F922CC03Q34109156-07CC4F0E-D29F-449B-8D49-9B03AE873441Q34482096-930CD660-693A-4005-869B-8E0E25193984Q34560565-11E748DA-499B-4D41-AA41-079EA844E704Q34795882-53B8D327-57E1-4542-A8A7-078B37A4BB65Q34805959-FB012584-2B08-4FA2-9DD8-47DCC4D8BBD4Q35121150-059DC12F-6552-4BB8-8BDF-432D3CC98FB9Q35238112-D1E295BE-9C56-44ED-BC40-A0C75D532DEFQ36464143-6CD9C717-0796-4C2D-AE78-A208CF192DBBQ36552242-81109F85-B105-4265-91E7-EF91C1E9E3A1Q36989765-A853A6BB-914F-4A13-9767-A1F2B55C872DQ37188336-6A76F4F0-8D9A-445E-8DF5-49F00BC3A3B2Q37297601-C5BD54F0-D898-477A-8466-F805CDA6C3ADQ37419638-107E8040-59E7-4E2C-AEE8-ABDC6B91C684Q37420911-87C0B02C-9C10-4700-83B0-35BBC8D8FDE8Q37730557-1A2F82B5-8E73-47D6-AF20-EAE3BBA27734Q37782589-B74EBF22-2CAC-4B5F-A497-8DE93043DC4DQ37786648-FDF48577-D0E6-4DC5-8EAB-27896BF63486Q37943005-09949063-033C-4D8B-AA73-F82E10A299B7Q38083874-CFA30963-1699-47BF-91F0-5DA220AAF3F2Q38178528-0AA0C090-FE45-45C2-9B3F-8F63E10ECD4CQ38214567-27967677-DCD0-49FD-A53C-8EF72E471D36Q38263671-82527AA1-A9B9-4E8E-AEB3-009FB321DCC9Q38358553-1CB61239-36EF-4C3B-8AF7-B4A0A73BDA95Q38402766-671D8A2B-5638-4400-BA1A-5825478AC74EQ38409356-32C0EC06-3193-4A54-8C85-707801C676BCQ38508194-AC7EA5F5-2963-4DFB-8DCD-35A0AD10954DQ38543383-4A0DB532-48E5-41E4-9DB6-F2A899488F96Q38556149-162F69E5-62C5-417B-8EC8-BBF20B1AA0EEQ38663003-AE62032D-B010-49EE-B730-026E9088B2A6Q38749160-55ED1A11-7A24-4C3A-AE7F-5F29B6058D18Q38768686-0B1F0084-F245-4DBD-BCE7-88F16EE000CFQ38787886-FA00181D-7FFB-4887-B73B-E4B2B7E3E4C0Q38941716-B7D1D19D-E361-409B-9D1C-320660E5B071
P2860
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Common inflammatory mediators ...... arthritis and atherosclerosis.
@en
Common inflammatory mediators ...... arthritis and atherosclerosis.
@nl
type
label
Common inflammatory mediators ...... arthritis and atherosclerosis.
@en
Common inflammatory mediators ...... arthritis and atherosclerosis.
@nl
prefLabel
Common inflammatory mediators ...... arthritis and atherosclerosis.
@en
Common inflammatory mediators ...... arthritis and atherosclerosis.
@nl
P2860
P921
P356
P1433
P1476
Common inflammatory mediators ...... arthritis and atherosclerosis.
@en
P2093
P2860
P356
10.1093/RHEUMATOLOGY/KEN395
P577
2008-10-16T00:00:00Z